Independent product intelligence · Worldwide · 2026-05-01 → 2026-07-31
Menten AI offers an advanced generative AI platform specifically designed for peptide therapeutics, overcoming traditional drug design limitations through machine learning and physics-based molecular modeling.
Traffic & engagement
Search demand
AI referral visibility
Product profile
Traffic makes more sense when you can connect it to the actual product promise.
“Menten AI”
Menten AI offers an advanced generative AI platform specifically designed for peptide therapeutics, overcoming traditional drug design limitations through machine learning and physics-based molecular modeling.
4 of 8 signal groups are available for this product: identity, authority and backlinks, AI referrals, search demand.
Not measured for this domain: traffic and engagement, audience demographics, country distribution, acquisition mix. Those sections are left out of the page rather than filled with estimates.
Canonical website: https://www.menten.ai
Observed across 1 discovery source.
Research questions
Every answer is tied to a source we collected, and the questions with no evidence behind them are left unanswered rather than guessed.
Menten AI's platform is a physics-based generative AI system for designing peptide drugs, specifically peptide macrocycles. It combines generative AI with physics-based models and quantum simulations to design and optimize drug-like peptides, aiming to overcome traditional drug design limitations. This is validated across the preclinical discovery pipeline.
The platform is designed to overcome traditional drug design limitations by creating peptide therapeutics. It addresses complex drug targets, including challenging Protein-Protein Interfaces, by designing peptide macrocycles from scratch (de novo) to create life-changing medicines.
The platform is used and trusted by top-10 pharmaceutical company partners, indicating its target users are large pharmaceutical and biotechnology companies engaged in drug discovery and development.
The platform, named MAUD 1.0, is a physics-based generative platform for designing peptide macrocycles. It has demonstrated capabilities including achieving nanomolar-level potency, oral bioavailability, cell-permeability, and a greater than 90% hit rate in preclinical validation.
Menten AI is a company that offers an advanced generative AI platform specifically designed for peptide therapeutics. The platform uses machine learning and physics-based molecular modeling to overcome traditional drug design limitations.
5 of 6 research questions are answered for this product. The rest need source evidence we have not collected yet, so they are left unanswered rather than guessed.
Behind the lock
Worldwide estimates · Data period 2026-05-01 → 2026-07-31. Figures are measured estimates intended for market research. Signals we have not measured for this domain are omitted, never estimated; a measured zero is still reported as zero. How this was measured